92 related articles for article (PubMed ID: 12710655)
1. Management of vertically HIV-infected children in Europe.
Thorne C; Gray L; Newell ML;
Acta Paediatr; 2003; 92(2):246-50. PubMed ID: 12710655
[TBL] [Abstract][Full Text] [Related]
2. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
[TBL] [Abstract][Full Text] [Related]
3. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
[TBL] [Abstract][Full Text] [Related]
4. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
Newell ML; Patel D; Goetghebuer T; Thorne C;
J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
6. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
[TBL] [Abstract][Full Text] [Related]
7. PENTA guidelines for the use of antiretroviral therapy, 2004.
Sharland M; Blanche S; Castelli G; Ramos J; Gibb DM;
HIV Med; 2004 Jul; 5 Suppl 2():61-86. PubMed ID: 15239717
[TBL] [Abstract][Full Text] [Related]
8. Care of HIV-infected pregnant women in maternal-fetal medicine programs.
Sklar PA; Bathgate SL; Young HA; Parenti DM
Infect Dis Obstet Gynecol; 2001; 9(2):81-7. PubMed ID: 11495558
[TBL] [Abstract][Full Text] [Related]
9. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
10. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.
European Collaborative Study
Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
12. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
13. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.
Warszawski J; Lechenadec J; Faye A; Dollfus C; Firtion G; Meyer L; Douard D; Monpoux F; Tricoire J; Benmebarek Y; Rouzioux C; Blanche S
Clin Infect Dis; 2007 Sep; 45(6):785-94. PubMed ID: 17712765
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
15. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
[TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.
Kline MW; Rugina S; Ilie M; Matusa RF; Schweitzer AM; Calles NR; Schwarzwald HL
Pediatrics; 2007 May; 119(5):e1116-20. PubMed ID: 17420261
[TBL] [Abstract][Full Text] [Related]
18. [Children and HIV/AIDS--prevention, follow up and treatment].
Wathne KO; Andersen GL
Tidsskr Nor Laegeforen; 2000 Jan; 120(2):210-4. PubMed ID: 10851918
[TBL] [Abstract][Full Text] [Related]
19. Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children.
Resino S; Bellon JM; Resino R; Navarro ML; Tomás Ramos J; de José MI; Mellado MJ; Muñoz-Fernández MA
Clin Infect Dis; 2004 Jun; 38(11):1605-12. PubMed ID: 15156450
[TBL] [Abstract][Full Text] [Related]
20. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]